STOCK TITAN

Caliber Imaging & Diagnostics Stock Price, News & Analysis

LCDX OTC Link

Company Description

Caliber Imaging & Diagnostics (OTC Link: LCDX) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $3.7M.

LCDX stock has gained 500.0% over the past year. Shares last traded at $0.0006.

This page provides a comprehensive overview of LCDX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
+500%
Performance 1 year

Caliber Imaging & Diagnostics (LCDX) stock last traded at $0.0006. Over the past 12 months, the stock has gained 500.0%. At a market capitalization of $3.7M, LCDX is classified as a micro-cap stock with approximately 8.5M shares outstanding.

Latest News

No recent news available for LCDX.

SEC Filings

No SEC filings available for LCDX.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Caliber Imaging & Diagnostics (LCDX) currently stands at 3.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Caliber Imaging & Diagnostics (LCDX) currently stands at 2.4 days, down 86.7% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 79.7% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 102.9 days.

LCDX Company Profile & Sector Positioning

Caliber Imaging & Diagnostics (LCDX) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.

Investors comparing LCDX often look at related companies in the same sector, including Odyssey Health Inc (ODYY), Qscreen AI Inc (PMEDF), Kelyniam Global Inc (KLYG), Lattice Biologic (LBLTF), and Bioelectronics Corp (BIEL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LCDX's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Caliber Imaging & Diagnostics (LCDX)?

The current stock price of Caliber Imaging & Diagnostics (LCDX) is $0.0006 as of April 6, 2026.

What is the market cap of Caliber Imaging & Diagnostics (LCDX)?

The market cap of Caliber Imaging & Diagnostics (LCDX) is approximately 3.7M. Learn more about what market capitalization means .